308.630.73
U.S. Pharmaceutical Policy

Location
Internet
Term
Winter Institute
Department
Health Policy and Management
Credit(s)
3
Academic Year
2024 - 2025
Instruction Method
Synchronous Online with Some Asynchronous Online
Class Time(s)
This course will be offered remotely January 6, 8, 10, 2025 from 9a-12p.
M, W, F, 9:00am - 12:00pm
Auditors Allowed
No
Available to Undergraduate
No
Grading Restriction
Letter Grade or Pass/Fail
Course Instructor(s)
Mariana Socal
Contact Name
Pamela Davis
Frequency Schedule
One Year Only
Next Offered
Only offered in 2024
Description
It is estimated that nearly 3 out of 5 Americans take prescription drugs on a regular basis. The number of individuals taking prescription drugs has been on the rise in recent decades, as is the number of drugs taken per person. These trends are expected to persist, largely due to the aging of the American population and the growing prevalence of conditions such as obesity and cardiovascular disease, whose treatments depend largely on pharmaceuticals.
Examines the pharmaceutical market and addresses the core issues related to pharmaceutical policy within the US health care system, such as drug pricing, regulation, and financing, drug coverage decisions, and ethical aspects of drug regulation. Considers the role of multiple health care system actors involved in and affected by pharmaceutical policy: drug manufacturers, drug regulation agencies, insurers, pharmaceutical benefits managers, health care providers, patients, families, and others. Provides an in-depth analysis of drug pricing strategies, coverage decisions, and access and affordability issues.
Learning Objectives
Upon successfully completing this course, students will be able to:
  1. Identify the role of the multiple actors involved in the US pharmaceutical market
  2. Explain how each actor in the market influences and is affected by pharmaceutical policies
  3. Differentiate between regulations for off-patent and patented pharmaceutical products
  4. Explain how pharmaceuticals are priced and financed in the US health care system
  5. Analyze pros and cons of alternative pharmaceutical pricing policies
  6. Propose and employ criteria to evaluate pharmaceutical policy options
Methods of Assessment
This course is evaluated as follows:
  • 25% In-class Exercises
  • 25% Quizzes
  • 50% Final policy paper
Enrollment Restriction
undergraduates not permitted in this course section
Instructor Consent
No consent required
Special Comments

Students must complete pre-course readings prior to the start of class. Assignments will be due on a date identified by the instructor. No assignment will be accepted after February 7, 2025.